+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

MRSA Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

MRSA Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 105 Pages
  • Global
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
Beta-2 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-2 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Dysautonomia Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Dysautonomia Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 98 Pages
  • Global
From
Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Crohn's Disease (CD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • May 2018
  • 204 Pages
  • Global
From
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 125 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease: Global Drug Forecast and Market Analysis to 2028

  • Report
  • March 2020
  • 154 Pages
  • Global
From
Asthma Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Asthma Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 2349 Pages
  • Global
From
Theravance Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Theravance Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Comprehensive Report on Theravance Biopharma Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Theravance Biopharma Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2024
  • 51 Pages
From
Loading Indicator